Oakland-based xCures raised $46 million in Series B funding in late June 2026, backed by Innovius Capital, iGrow, GKCC, Spring Mountain Capital, and existing investors, bringing its total raised to more than $76 million at a $127 million post-money valuation.
The company operates in health AI and clinical data infrastructure, a category that has quietly attracted some of the most consistent capital of 2026 even as headlines focus on consumer AI. xCures' work sits inside a broader wave of startups building the data plumbing that lets hospitals, oncologists, and research networks make faster, better-informed treatment decisions.
The round is part of a pattern seen throughout June: healthcare administrative and clinical AI companies pulling in large, disciplined rounds from investors who have grown far more selective about which AI use cases actually reduce cost or improve outcomes rather than simply automating existing paperwork.
For founders building in health AI, xCures' trajectory β several funding rounds building toward a genuine infrastructure position rather than a single flashy product launch β is a useful template for how patient, systems-level plays get funded in a tightened market.